Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing

Proceeds will support ongoing clinical evaluation of HepaStem® in ACLF and launch of a clinical trial in late stage NASH set to commence in H1 2019 in Europe with significant further expansion into the US and Asia. Discover the press release here.   

Read more

Belgian BioPharma Industry 2018 numbers

37.073 people employed, €3.6bn invested in R&D, €43bn drugs and vaccines exports. Discover the full 2018 report here.

Read more